Targeting Lactate Dehydrogenase A with Catechin Resensitizes SNU620/5FU Gastric Cancer Cells to 5-Fluorouracil

Resistance to anticancer therapeutics occurs in virtually every type of cancer and becomes a major difficulty in cancer treatment. Although 5-fluorouracil (5FU) is the first-line choice of anticancer therapy for gastric cancer, its effectiveness is limited owing to drug resistance. Recently, altered...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jung Ho, Kim, MinJeong, Kim, Hyeon Jin, Jang, Se Bok, Bae, Sung-Jin, Lee, In-Kyu, Ryu, Dongryeol, Ha, Ki-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161398/
https://www.ncbi.nlm.nih.gov/pubmed/34065602
http://dx.doi.org/10.3390/ijms22105406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161398/
https://www.ncbi.nlm.nih.gov/pubmed/34065602
http://dx.doi.org/10.3390/ijms22105406

Ejemplares similares